AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $748,353 | +30.6% | 656,450 | +4.9% | 0.00% | – |
| Q2 2023 | $572,836 | +47.5% | 626,050 | -9.6% | 0.00% | – |
| Q1 2023 | $388,265 | -41.2% | 692,836 | -39.4% | 0.00% | – |
| Q4 2022 | $660,014 | +264.6% | 1,143,872 | +100.0% | 0.00% | – |
| Q3 2022 | $181,000 | -10.8% | 571,936 | -0.3% | 0.00% | – |
| Q2 2022 | $203,000 | -97.5% | 573,876 | -95.0% | 0.00% | – |
| Q1 2022 | $8,247,000 | -68.9% | 11,488,224 | -2.2% | 0.00% | -100.0% |
| Q4 2021 | $26,540,000 | -41.9% | 11,743,461 | -25.9% | 0.00% | -50.0% |
| Q3 2021 | $45,667,000 | -14.0% | 15,856,428 | +13.2% | 0.00% | -33.3% |
| Q2 2021 | $53,085,000 | -8.0% | 14,006,637 | -17.8% | 0.00% | 0.0% |
| Q1 2021 | $57,695,000 | -8.3% | 17,044,176 | -24.2% | 0.00% | -25.0% |
| Q4 2020 | $62,934,000 | +63.4% | 22,476,534 | +46.5% | 0.00% | +33.3% |
| Q3 2020 | $38,505,000 | -43.4% | 15,340,471 | +206.1% | 0.00% | -40.0% |
| Q2 2020 | $68,063,000 | +162.8% | 5,012,038 | +46.7% | 0.01% | +150.0% |
| Q1 2020 | $25,900,000 | +19.1% | 3,416,930 | -0.7% | 0.00% | +100.0% |
| Q4 2019 | $21,753,000 | +52.2% | 3,441,996 | -5.6% | 0.00% | 0.0% |
| Q3 2019 | $14,291,000 | -49.1% | 3,645,657 | -37.1% | 0.00% | -50.0% |
| Q2 2019 | $28,066,000 | +1.3% | 5,798,682 | +71.5% | 0.00% | 0.0% |
| Q1 2019 | $27,698,000 | +89.9% | 3,381,967 | +28.2% | 0.00% | +100.0% |
| Q4 2018 | $14,587,000 | -27.6% | 2,637,846 | +15.6% | 0.00% | -50.0% |
| Q3 2018 | $20,143,000 | +4.5% | 2,281,142 | +18.2% | 0.00% | 0.0% |
| Q2 2018 | $19,267,000 | +34.8% | 1,930,404 | +28.7% | 0.00% | +100.0% |
| Q1 2018 | $14,297,000 | -35.3% | 1,500,213 | +0.9% | 0.00% | -50.0% |
| Q4 2017 | $22,100,000 | -12.8% | 1,486,239 | +15.3% | 0.00% | 0.0% |
| Q3 2017 | $25,355,000 | +86.4% | 1,288,886 | +36.1% | 0.00% | +100.0% |
| Q2 2017 | $13,604,000 | +170.0% | 946,888 | +72.9% | 0.00% | – |
| Q1 2017 | $5,038,000 | -8.9% | 547,728 | +3.0% | 0.00% | -100.0% |
| Q4 2016 | $5,528,000 | +18.9% | 531,581 | +3.5% | 0.00% | – |
| Q3 2016 | $4,649,000 | +28.0% | 513,764 | +5.6% | 0.00% | – |
| Q2 2016 | $3,633,000 | -4.7% | 486,333 | +15.0% | 0.00% | – |
| Q1 2016 | $3,811,000 | -3.0% | 422,771 | +39.0% | 0.00% | – |
| Q4 2015 | $3,930,000 | +46.7% | 304,210 | +9.8% | 0.00% | – |
| Q3 2015 | $2,679,000 | +12.7% | 277,138 | +19.9% | 0.00% | – |
| Q2 2015 | $2,378,000 | +107.7% | 231,110 | +123.7% | 0.00% | – |
| Q1 2015 | $1,145,000 | +0.1% | 103,294 | +4.7% | 0.00% | – |
| Q4 2014 | $1,144,000 | -31.3% | 98,616 | +31.1% | 0.00% | – |
| Q3 2014 | $1,665,000 | -17.9% | 75,209 | +3.1% | 0.00% | – |
| Q2 2014 | $2,027,000 | – | 72,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |